International standards for monoclonal antibodies to support pre- and post-marketing product consistency: Evaluation of a candidate international standard for the bioactivities of rituximab.
about
International standards for monoclonal antibodies to support pre- and post-marketing product consistency: Evaluation of a candidate international standard for the bioactivities of rituximab.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
International standards for mo ...... he bioactivities of rituximab.
@en
International standards for mo ...... he bioactivities of rituximab.
@nl
type
label
International standards for mo ...... he bioactivities of rituximab.
@en
International standards for mo ...... he bioactivities of rituximab.
@nl
prefLabel
International standards for mo ...... he bioactivities of rituximab.
@en
International standards for mo ...... he bioactivities of rituximab.
@nl
P2093
P2860
P1476
International standards for mo ...... he bioactivities of rituximab.
@en
P2093
Adrian Bristow
Peter Rigsby
Sandra Prior
Simon E Hufton
Thomas Dougall
participants of the study
P2860
P304
P356
10.1080/19420862.2017.1386824
P50
P577
2017-10-06T00:00:00Z